MTVA (MetaVia) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTVA MetaVia Inc MTVA
28 GF Score
Price $1.73
! 1 Warning Sign
View Full Analysis

What is MetaVia Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MetaVia  (NAS:MTVA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


MetaVia Cyclically Adjusted PB Ratio Related Terms


MetaVia Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for MetaVia's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaVia Cyclically Adjusted PB Ratio Chart

MetaVia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.00

MetaVia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.00 0.00 0.00

MTVA vs VTGN, TOVX, GDTC: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, MetaVia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MetaVia Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MetaVia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MetaVia's Cyclically Adjusted PB Ratio falls into.


MTVA
28GF Score
MetaVia Inc MTVA
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MetaVia Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

MetaVia's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, MetaVia's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.037/333.9520*333.9520
=1.037

Current CPI (Jun. 2026) = 333.9520.

MetaVia Quarterly Data

Book Value per Share CPI Adj_Book
201609 192,142.286 241.428 265,778.206
201612 146,890.457 241.432 203,180.862
201703 157,556.624 243.801 215,816.792
201706 110,317.732 244.955 150,398.348
201709 61,754.105 246.819 83,554.778
201712 24,462.049 246.524 33,137.342
201803 96,535.396 249.554 129,183.217
201806 69,782.612 251.989 92,480.397
201809 50,212.223 252.439 66,425.839
201812 35,966.998 251.233 47,809.209
201903 20,569.754 254.202 27,023.039
201906 9,086.594 256.143 11,846.844
201909 -4,548.691 256.759 -5,916.227
201912 2,081.156 256.974 2,704.578
202003 1,303.387 258.115 1,686.336
202006 1,982.816 257.797 2,568.553
202009 1,527.690 260.280 1,960.101
202012 966.689 260.474 1,239.386
202103 1,565.935 264.877 1,974.302
202106 1,122.790 271.696 1,380.064
202109 725.584 274.310 883.344
202112 1,445.368 278.802 1,731.277
202203 1,181.089 287.504 1,371.901
202206 874.628 296.311 985.734
202209 587.992 296.808 661.576
202212 75.248 296.797 84.668
202303 66.406 301.836 73.472
202306 57.980 305.109 63.461
202309 49.348 307.789 53.543
202312 37.410 306.746 40.728
202403 22.592 312.332 24.156
202406 25.345 314.175 26.940
202409 16.550 315.301 17.529
202412 10.101 315.605 10.688
202503 5.567 319.799 5.813
202506 4.376 322.561 4.531
202509 2.876 324.800 2.957
202512 2.310 324.054 2.381
202603 1.757 330.213 1.777
202606 1.037 333.952 1.037

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MetaVia Business Description

Address 545 Concord Avenue, Suite 210, Cambridge, MA, USA, 02138
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
28GF Score

Get the complete analysis for MTVA

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.73
Price